Intro to Market Research

Novice entrepreneurs in the pre-launch stage of development are the target audience for this workshop led by TechTown mentor and business expert Wendy Richardson. Admission is $10 per person and open to the public. To learn more, click here.

Interested in Detroit Ann Arbor Events?

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
COVID-19 Special Report: Sustaining Clinical Research During the Crisis
Leveraging technology & expertise to ensure a continual journey from trials to treatments
PRA Health Sciences

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Webinar
Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug Discovery
In vitro assays that tackle the challenges of in vitro hepatotoxicity assessment
Eurofins Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Detroit Ann Arbor

FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

Cara Therapeutics Itching Drug Scratches Off Goals of Phase 3 Test

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

Intro to Market Research

Share

Interested in Detroit Ann Arbor Events?

Underwriters and Partners

COVID-19 Special Report: Sustaining Clinical Research During the Crisis

Potency Assay Development for Cell and Gene Therapy Products

Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!